BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37880686)

  • 21. Sensitivity to asbestos is increased in patients with mesothelioma and pathogenic germline variants in BAP1 or other DNA repair genes.
    Betti M; Aspesi A; Ferrante D; Sculco M; Righi L; Mirabelli D; Napoli F; Rondón-Lagos M; Casalone E; Vignolo Lutati F; Ogliara P; Bironzo P; Gironi CL; Savoia P; Maffè A; Ungari S; Grosso F; Libener R; Boldorini R; Valiante M; Pasini B; Matullo G; Scagliotti G; Magnani C; Dianzani I
    Genes Chromosomes Cancer; 2018 Nov; 57(11):573-583. PubMed ID: 30338612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesothelioma and Colorectal Cancer: Report of Four Cases with Synchronous and Metachronous Presentation.
    Serio G; Pezzuto F; Fortarezza F; Marzullo A; Delfino MC; d'Amati A; Romano DE; Maniglio S; Caporusso C; Lettini T; Cavone D; Vimercati L
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.
    Carbone M; Pass HI; Ak G; Alexander HR; Baas P; Baumann F; Blakely AM; Bueno R; Bzura A; Cardillo G; Churpek JE; Dianzani I; De Rienzo A; Emi M; Emri S; Felley-Bosco E; Fennell DA; Flores RM; Grosso F; Hayward NK; Hesdorffer M; Hoang CD; Johansson PA; Kindler HL; Kittaneh M; Krausz T; Mansfield A; Metintas M; Minaai M; Mutti L; Nielsen M; O'Byrne K; Opitz I; Pastorino S; Pentimalli F; de Perrot M; Pritchard A; Ripley RT; Robinson B; Rusch V; Taioli E; Takinishi Y; Tanji M; Tsao AS; Tuncer AM; Walpole S; Wolf A; Yang H; Yoshikawa Y; Zolondick A; Schrump DS; Hassan R
    J Thorac Oncol; 2022 Jul; 17(7):873-889. PubMed ID: 35462085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of germline mutations in BAP1 in sporadic cases of malignant mesothelioma.
    Sneddon S; Leon JS; Dick IM; Cadby G; Olsen N; Brims F; Allcock RJ; Moses EK; Melton PE; de Klerk N; Musk AW; Robinson BW; Creaney J
    Gene; 2015 May; 563(1):103-5. PubMed ID: 25796603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningiomas in Patients With Malignant Pleural Mesothelioma Harboring Germline BAP1 Mutations.
    Hu ZI; Miettinen M; Quezado M; Lebensohn AP; Aldape K; Agra M; Wagner C; Mallory Y; Hassan R; Ghafoor A
    J Thorac Oncol; 2022 Mar; 17(3):461-466. PubMed ID: 34628055
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How asbestos and other fibers cause mesothelioma.
    Gaudino G; Xue J; Yang H
    Transl Lung Cancer Res; 2020 Feb; 9(Suppl 1):S39-S46. PubMed ID: 32206569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detecting germline BAP1 mutations in patients with peritoneal mesothelioma: benefits to patient and family members.
    Kittaneh M; Berkelhammer C
    J Transl Med; 2018 Jul; 16(1):194. PubMed ID: 30001711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of
    Kukuyan AM; Sementino E; Kadariya Y; Menges CW; Cheung M; Tan Y; Cai KQ; Slifker MJ; Peri S; Klein-Szanto AJ; Rauscher FJ; Testa JR
    Cancer Res; 2019 Aug; 79(16):4113-4123. PubMed ID: 31151962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients.
    Napolitano A; Antoine DJ; Pellegrini L; Baumann F; Pagano I; Pastorino S; Goparaju CM; Prokrym K; Canino C; Pass HI; Carbone M; Yang H
    Clin Cancer Res; 2016 Jun; 22(12):3087-96. PubMed ID: 26733616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma.
    Carbone M; Yang H
    Clin Cancer Res; 2012 Feb; 18(3):598-604. PubMed ID: 22065079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Driver Gene and Novel Mutations in Asbestos-Exposed Lung Adenocarcinoma and Malignant Mesothelioma Detected by Exome Sequencing.
    Mäki-Nevala S; Sarhadi VK; Knuuttila A; Scheinin I; Ellonen P; Lagström S; Rönty M; Kettunen E; Husgafvel-Pursiainen K; Wolff H; Knuutila S
    Lung; 2016 Feb; 194(1):125-35. PubMed ID: 26463840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesothelioma epidemiology, carcinogenesis, and pathogenesis.
    Yang H; Testa JR; Carbone M
    Curr Treat Options Oncol; 2008 Jun; 9(2-3):147-57. PubMed ID: 18709470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the diagnosis of mesothelioma and BAP1 protein expression in a cohort of asbestos textile workers from Northern Italy.
    Boffetta P; Righi L; Ciocan C; Pelucchi C; La Vecchia C; Romano C; Papotti M; Pira E
    Ann Oncol; 2018 Feb; 29(2):484-489. PubMed ID: 29206890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics of patients with malignant pleural mesothelioma harboring somatic BAP1 mutations.
    Zauderer MG; Bott M; McMillan R; Sima CS; Rusch V; Krug LM; Ladanyi M
    J Thorac Oncol; 2013 Nov; 8(11):1430-3. PubMed ID: 24128712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asbestos induces mesothelial cell transformation via HMGB1-driven autophagy.
    Xue J; Patergnani S; Giorgi C; Suarez J; Goto K; Bononi A; Tanji M; Novelli F; Pastorino S; Xu R; Caroccia N; Dogan AU; Pass HI; Tognon M; Pinton P; Gaudino G; Mak TW; Carbone M; Yang H
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25543-25552. PubMed ID: 32999071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies.
    Bononi A; Napolitano A; Pass HI; Yang H; Carbone M
    Expert Rev Respir Med; 2015 Oct; 9(5):633-54. PubMed ID: 26308799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BAP1 regulates IP3R3-mediated Ca
    Bononi A; Giorgi C; Patergnani S; Larson D; Verbruggen K; Tanji M; Pellegrini L; Signorato V; Olivetto F; Pastorino S; Nasu M; Napolitano A; Gaudino G; Morris P; Sakamoto G; Ferris LK; Danese A; Raimondi A; Tacchetti C; Kuchay S; Pass HI; Affar EB; Yang H; Pinton P; Carbone M
    Nature; 2017 Jun; 546(7659):549-553. PubMed ID: 28614305
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.
    Wang Y; Jiang Z; Yan J; Ying S
    Dis Markers; 2019; 2019():4183157. PubMed ID: 30891101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Authors' response: Mezei et al's "Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis".
    Marinaccio A; Consonni D; Mensi C; Mirabelli D; Migliore E; Magnani C; Di Marzio D; Gennaro V; Mazzoleni G; Girardi P; Negro C; Romanelli A; Chellini E; Grappasonni I; Madeo G; Romeo E; Ascoli V; Carrozza F; Angelillo IF; Cavone D; Tumino R; Melis M; Curti S; Brandi G; Mattioli S; Iavicoli S;
    Scand J Work Environ Health; 2021 Jan; 47(1):87-89. PubMed ID: 33388783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAP1 mutation is a frequent somatic event in peritoneal malignant mesothelioma.
    Alakus H; Yost SE; Woo B; French R; Lin GY; Jepsen K; Frazer KA; Lowy AM; Harismendy O
    J Transl Med; 2015 Apr; 13():122. PubMed ID: 25889843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.